NO20005200L - Nye polycykliske azaindolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye polycykliske azaindolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number: NO20005200L
Authority: NO; Norway
Prior art keywords: alkyl; group; alkoxy; polyhaloalkyl; optionally substituted
Prior art date: 1999-10-15

Application number

NO20005200A

Other languages

English (en)

Other versions

NO20005200D0 (no

NO317884B1 (no

Inventor

Gerald Guillaumet

Marie-Claude Viaud

Herve Van De Poel

Philippe Delagrange

Caroline Bennejean

Pierre Renard

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-15

Filing date

2000-10-16

Publication date

2001-04-17

2000-10-16 Application filed by Adir filed Critical Adir

2000-10-16 Publication of NO20005200D0 publication Critical patent/NO20005200D0/no

2001-04-17 Publication of NO20005200L publication Critical patent/NO20005200L/no

2004-12-27 Publication of NO317884B1 publication Critical patent/NO317884B1/no

Links

-1 polycyclic azaindole compounds Chemical class 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 7
125000003545 alkoxy group Chemical group 0.000 abstract 5
229910052736 halogen Inorganic materials 0.000 abstract 4
150000002367 halogens Chemical class 0.000 abstract 4
125000006684 polyhaloalkyl group Polymers 0.000 abstract 4
125000001072 heteroaryl group Chemical group 0.000 abstract 3
125000004043 oxo group Chemical group O=* 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000002947 alkylene group Chemical group 0.000 abstract 2
125000000304 alkynyl group Chemical group 0.000 abstract 2
125000003368 amide group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000004093 cyano group Chemical group *C#N 0.000 abstract 2
125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
239000000543 intermediate Substances 0.000 abstract 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
229910052760 oxygen Inorganic materials 0.000 abstract 2
125000004193 piperazinyl group Chemical group 0.000 abstract 2
125000003367 polycyclic group Chemical group 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000000719 pyrrolidinyl group Chemical group 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
235000010290 biphenyl Nutrition 0.000 abstract 1
239000004305 biphenyl Substances 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000002993 cycloalkylene group Chemical group 0.000 abstract 1
125000002541 furyl group Chemical group 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000002883 imidazolyl group Chemical group 0.000 abstract 1
125000001041 indolyl group Chemical group 0.000 abstract 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000003386 piperidinyl group Chemical group 0.000 abstract 1
125000003373 pyrazinyl group Chemical group 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
125000005493 quinolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Obesity (AREA)
Cardiology (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Gynecology & Obstetrics (AREA)
Anesthesiology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Indole Compounds (AREA)

NO20005200A 1999-10-15 2000-10-16 Nye polycykliske azaindolforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO317884B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9912900A FR2799757B1 (fr)	1999-10-15	1999-10-15	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number	Publication Date
NO20005200D0 NO20005200D0 (no)	2000-10-16
NO20005200L true NO20005200L (no)	2001-04-17
NO317884B1 NO317884B1 (no)	2004-12-27

Family

ID=9550991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005200A NO317884B1 (no)	1999-10-15	2000-10-16	Nye polycykliske azaindolforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (22)

Country	Link
US (3)	US6495543B1 (no)
EP (1)	EP1092717B1 (no)
JP (1)	JP3519357B2 (no)
KR (1)	KR100460783B1 (no)
CN (1)	CN1151152C (no)
AT (1)	ATE230745T1 (no)
AU (1)	AU772126B2 (no)
BR (1)	BR0004823A (no)
CA (1)	CA2323720C (no)
DE (1)	DE60001138T2 (no)
DK (1)	DK1092717T3 (no)
EA (1)	EA003666B1 (no)
ES (1)	ES2189730T3 (no)
FR (1)	FR2799757B1 (no)
HU (1)	HUP0004007A3 (no)
MX (1)	MXPA00009729A (no)
NO (1)	NO317884B1 (no)
NZ (1)	NZ507525A (no)
PL (1)	PL343187A1 (no)
PT (1)	PT1092717E (no)
SI (1)	SI1092717T1 (no)
ZA (1)	ZA200005667B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6269533B2 (en) *	1999-02-23	2001-08-07	Advanced Research Corporation	Method of making a patterned magnetic recording head
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1132389A1 (en) *	2000-03-06	2001-09-12	Vernalis Research Limited	New aza-indolyl derivatives for the treatment of obesity
DE10143079A1 (de) *	2001-09-03	2003-05-15	Zentaris Ag	Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
US20050267303A1 (en) *	2001-09-04	2005-12-01	Zentaris Ag	Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
GB0202015D0 (en) *	2002-01-29	2002-03-13	Hoffmann La Roche	Piperazine Derivatives
US7595311B2 (en) *	2002-05-24	2009-09-29	Exelixis, Inc.	Azepinoindole derivatives as pharmaceutical agents
TWI329111B (en) *	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents
MXPA05005700A (es)	2002-11-28	2005-08-16	Suven Life Sciences Ltd	N-arilsulfonil-3-aminoalcoxiindoles.
EA009367B1 (ru) *	2002-12-18	2007-12-28	Сувен Лайф Сайенсиз Лимитед	ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА
DE202007014474U1 (de) *	2007-10-16	2009-03-05	Schwan-Stabilo Cosmetics Gmbh & Co. Kg	Aufgespritzte Applikatoren
TW201018695A (en) *	2008-07-30	2010-05-16	Ferrer Int	1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds
CA2736571A1 (en)	2008-09-22	2010-03-25	Merck Frosst Canada Ltd.	Azaindole derivatives as crth2 receptor antagonists

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3912729A (en) *	1972-02-14	1975-10-14	Ayerst Mckenna & Harrison	Oxazinoindole- and thiazinoindole derivatives
US3910901A (en) *	1972-02-14	1975-10-07	Ayerst Mckenna & Harrison	Oxazinoindole- and thiazinoindole derivatives
US3962236A (en) *	1972-02-14	1976-06-08	Ayerst Mckenna And Harrison Ltd.	Oxazinoindole- and thiazinoindole derivatives
US3910903A (en) *	1974-02-14	1975-10-07	Ayerst Mckenna & Harrison	Oxazinoindole- and thiazinoindole derivatives
US4012511A (en) *	1974-05-28	1977-03-15	Ayerst Mckenna & Harrison Ltd.	Oxazinoindole derivatives useful as antidepressants
US4066763A (en) *	1975-07-07	1978-01-03	Ayerst Mckenna And Harrison Ltd.	Thiazinoindoles useful as antidepressants
EP0183993A3 (de) *	1984-11-16	1987-12-09	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
DE3674028D1 (de) *	1985-03-12	1990-10-18	Ciba Geigy Ag	Heterocyclisch kondensierte pyridin-verbindungen als herbizide.
DK155524C (da) *	1987-03-18	1989-09-11	Ferrosan As	Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
EP0572863A1 (de) *	1992-06-05	1993-12-08	F. Hoffmann-La Roche Ag	ZNS Pyrazinoindole
MX9305947A (es) *	1992-09-29	1994-06-30	Smithkline Beecham Plc	Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
FR2732969B1 (fr) *	1995-04-14	1997-05-16	Adir	Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2762598A1 (fr) *	1997-04-25	1998-10-30	Adir	Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent
FR2763335B1 (fr) *	1997-05-16	2000-11-24	Adir	Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2766824B1 (fr) *	1997-07-30	1999-09-10	Adir	Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9902047D0 (en) *	1999-01-29	1999-03-17	Cerebrus Ltd	Chemical compounds XI
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0019117D0 (en) *	2000-08-03	2000-09-27	Univ Barcelona	Derivatives of variolin B
JP2006506846A (ja) *	2002-11-12	2006-02-23	ゼテーラ・コーポレイシヨン	改良型通信機能付き電気装置

1999
- 1999-10-15 FR FR9912900A patent/FR2799757B1/fr not_active Expired - Fee Related
2000
- 2000-10-04 MX MXPA00009729A patent/MXPA00009729A/es active IP Right Grant
- 2000-10-12 US US09/689,578 patent/US6495543B1/en not_active Expired - Fee Related
- 2000-10-13 SI SI200030043T patent/SI1092717T1/xx unknown
- 2000-10-13 AT AT00402832T patent/ATE230745T1/de not_active IP Right Cessation
- 2000-10-13 CA CA002323720A patent/CA2323720C/fr not_active Expired - Fee Related
- 2000-10-13 DK DK00402832T patent/DK1092717T3/da active
- 2000-10-13 EP EP00402832A patent/EP1092717B1/fr not_active Expired - Lifetime
- 2000-10-13 ZA ZA200005667A patent/ZA200005667B/xx unknown
- 2000-10-13 ES ES00402832T patent/ES2189730T3/es not_active Expired - Lifetime
- 2000-10-13 DE DE60001138T patent/DE60001138T2/de not_active Expired - Fee Related
- 2000-10-13 AU AU66502/00A patent/AU772126B2/en not_active Ceased
- 2000-10-13 CN CNB001304739A patent/CN1151152C/zh not_active Expired - Fee Related
- 2000-10-13 HU HU0004007A patent/HUP0004007A3/hu unknown
- 2000-10-13 PL PL00343187A patent/PL343187A1/xx not_active Application Discontinuation
- 2000-10-13 NZ NZ507525A patent/NZ507525A/en unknown
- 2000-10-13 PT PT00402832T patent/PT1092717E/pt unknown
- 2000-10-13 EA EA200000948A patent/EA003666B1/ru not_active IP Right Cessation
- 2000-10-13 BR BR0004823-2A patent/BR0004823A/pt not_active Application Discontinuation
- 2000-10-13 JP JP2000314109A patent/JP3519357B2/ja not_active Expired - Fee Related
- 2000-10-16 NO NO20005200A patent/NO317884B1/no not_active IP Right Cessation
- 2000-10-16 KR KR10-2000-0060725A patent/KR100460783B1/ko not_active Expired - Fee Related
2002
- 2002-10-09 US US10/267,238 patent/US6667304B2/en not_active Expired - Fee Related
- 2002-10-09 US US10/267,303 patent/US7235550B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PT1092717E (pt)	2003-04-30
US6667304B2 (en)	2003-12-23
DK1092717T3 (da)	2003-04-14
DE60001138D1 (de)	2003-02-13
EA200000948A1 (ru)	2001-04-23
EA003666B1 (ru)	2003-08-28
US20030134847A1 (en)	2003-07-17
BR0004823A (pt)	2001-05-22
MXPA00009729A (es)	2002-06-04
CA2323720A1 (fr)	2001-04-15
KR20010067334A (ko)	2001-07-12
HU0004007D0 (en)	2000-12-28
JP2001114781A (ja)	2001-04-24
HUP0004007A3 (en)	2002-06-28
EP1092717A3 (fr)	2001-10-04
FR2799757A1 (fr)	2001-04-20
HK1036061A1 (en)	2001-12-21
US7235550B2 (en)	2007-06-26
NO20005200D0 (no)	2000-10-16
EP1092717A2 (fr)	2001-04-18
AU772126B2 (en)	2004-04-08
US6495543B1 (en)	2002-12-17
US20030105087A1 (en)	2003-06-05
KR100460783B1 (ko)	2004-12-09
ES2189730T3 (es)	2003-07-16
ZA200005667B (en)	2001-05-15
JP3519357B2 (ja)	2004-04-12
CN1151152C (zh)	2004-05-26
CN1293195A (zh)	2001-05-02
ATE230745T1 (de)	2003-01-15
DE60001138T2 (de)	2003-10-23
HUP0004007A2 (hu)	2001-05-28
AU6650200A (en)	2001-04-26
NZ507525A (en)	2001-09-28
EP1092717B1 (fr)	2003-01-08
SI1092717T1 (en)	2003-04-30
NO317884B1 (no)	2004-12-27
FR2799757B1 (fr)	2001-12-14
PL343187A1 (en)	2001-04-23
CA2323720C (fr)	2005-02-15

Legal Events

Date	Code	Title	Description
2010-05-31	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20005200L (no)	2001-04-17	Nye polycykliske azaindolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
PE20220597A1 (es)	2022-04-22	Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
AR018204A1 (es)	2001-10-31	METODO PARA LA PREPARACIOON DE CITALOPRAM , INTERMEDIARIO PARA LA PREPARACION DE CITALOPRAM Y EL USO DEL INTERMEDIARIO PARA LA PREPARACIoN DE CITALOPRAM
AR035234A1 (es)	2004-05-05	Aril y biaril-piperidinas con actividad moduladora mch, metodo para preparar dichos compuestos, composiciones farmaceuticas, metodo para preparar las composiciones farmaceuticas y el uso de dichos compuestos para la manufactura de un medicamento
EA200400944A1 (ru)	2005-04-28	Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
AR043015A1 (es)	2005-07-13	Compuestos moduladores de amida derivada de quinolina del receptor vanilloide vr1, composiciones farmaceuticas y veterinarias que los contienen y su uso en el tratamiento de enfermedades afectadas por la modulacion de dichos receptores
AR036606A1 (es)	2004-09-22	Tratamiento con antranilamidas artropodicidas
CY1112642T1 (el)	2016-02-10	Παραγωγα 4-(πυριδιν-4-υλο)-1η-[1,3,5]τριαζιν-2-ονης ως αναστολεις της gsκ3-βετα για τη θεραπεια των νευροεκφυλιστικων ασθενειων
AR044502A1 (es)	2005-09-14	Quinazolinas utiles como moduladores de canales ionicos
AR074790A1 (es)	2011-02-09	Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente.
PE20021089A1 (es)	2003-02-18	Compuestos de triazol como inhibidores de las citoquinas
JP2009523732A5 (no)	2010-03-04
AR067975A1 (es)	2009-10-28	Derivados de la n-bencil, n-arilcarbonilpiperazina
CA2169737A1 (en)	1995-02-23	Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
NO974455D0 (no)	1997-09-26	Nye falvonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem
AR045796A1 (es)	2005-11-16	Derivados de hexa y octahidro - pirido (1,2-a) pirazina con actividad antagonista de nk1. composiciones farmaceuticas.
NO974563L (no)	1997-11-24	Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
FR2788772B1 (fr)	2001-03-02	Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO20005807L (no)	2001-05-21	Nye kamptotekinanaloge forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
CO5031336A1 (es)	2001-04-27	Mezclas fungicidas que contienen carbamatos y un derivado aromatico
AR040276A1 (es)	2005-03-23	Derivados de 3-(4-oxo-4h-cromen-2-il)-(1h)-quinolein-4-onas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
GB1070333A (en)	1967-06-01	New quinolone derivatives and compositions comprising them
CY1108404T1 (el)	2014-02-12	Βητα-λακταμες για θεραπεια διαταραχων του κνς
NO964672D0 (no)	1996-11-05	Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem
FR2757859B1 (fr)	1999-01-29	Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent